Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	5.09e-07	37	163	6	GO:0140658
GeneOntologyMolecularFunction	cytoskeletal protein binding	FKBP15 TRPM7 SPTA1 PPP1R9A DPYSL4 EPS8L1 INO80 EPB41L4A CLSTN1 DYSF JAKMIP2 FARP2 TUBGCP6 TLNRD1 SLC8A1 PDLIM3 MYH14 SIPA1L1 MYO3B SYNE2 MAST1 KIF5C CROCC	3.08e-05	1099	163	23	GO:0008092
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	TTF2 CHD8 CHD3 INO80 SMARCA2 MLH1 SMARCA4	8.35e-05	127	163	7	GO:0008094
GeneOntologyMolecularFunction	actin binding	FKBP15 TRPM7 SPTA1 PPP1R9A EPS8L1 INO80 TLNRD1 PDLIM3 MYH14 SIPA1L1 MYO3B SYNE2 CROCC	1.59e-04	479	163	13	GO:0003779
GeneOntologyMolecularFunction	histone binding	IPO7 ING1 CHD8 CHD3 INO80 SMARCA2 SMARCA4 KMT2A WDTC1	3.37e-04	265	163	9	GO:0042393
GeneOntologyMolecularFunction	synaptic receptor adaptor activity	SHANK1 SHANK2	3.93e-04	4	163	2	GO:0030160
GeneOntologyMolecularFunction	ATP-dependent activity	ATP8B3 TTF2 ATP7A CHD8 CHD3 INO80 MDN1 MYH14 MYO3B SMARCA2 MLH1 SMARCA4 KIF5C DNAH8	5.25e-04	614	163	14	GO:0140657
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL6A2 COL11A1 COL13A1 COL6A6	5.35e-04	46	163	4	GO:0030020
GeneOntologyBiologicalProcess	actin filament-based process	SHANK1 TRPM7 SPTA1 PPP1R9A MYOM3 EPB41L4A ARHGEF17 FARP2 PLEK2 PDLIM3 MYH14 PPM1F TESK2 SIPA1L1 MYO3B SYNE2 FZD10 ARHGAP25 PRKCQ BAIAP2 NOS1	9.86e-06	912	162	21	GO:0030029
GeneOntologyBiologicalProcess	actin cytoskeleton organization	SHANK1 TRPM7 SPTA1 PPP1R9A MYOM3 EPB41L4A ARHGEF17 FARP2 PLEK2 PDLIM3 MYH14 PPM1F TESK2 SIPA1L1 MYO3B FZD10 ARHGAP25 PRKCQ BAIAP2	1.86e-05	803	162	19	GO:0030036
GeneOntologyCellularComponent	cell leading edge	ERBB2 ATP7A TRPM7 PPP1R9A EPS8L1 GRIN1 PLXND1 DYSF TUBG1 PLEK2 SYNE2 BAIAP2 MCF2L GABRA4	3.41e-05	500	161	14	GO:0031252
GeneOntologyCellularComponent	dendritic spine	SHANK1 PPP1R9A GRIN1 CLSTN1 SLC8A1 SHANK2 SIPA1L1 BAIAP2 NOS1	1.12e-04	242	161	9	GO:0043197
GeneOntologyCellularComponent	neuron spine	SHANK1 PPP1R9A GRIN1 CLSTN1 SLC8A1 SHANK2 SIPA1L1 BAIAP2 NOS1	1.30e-04	247	161	9	GO:0044309
GeneOntologyCellularComponent	postsynaptic specialization	SHANK1 ATP7A PPP1R9A GRIN1 CLSTN1 CRHR1 CHRND SLC8A1 SHANK2 SIPA1L1 BAIAP2 NOS1 GABRA4	1.46e-04	503	161	13	GO:0099572
GeneOntologyCellularComponent	gamma-tubulin complex	TUBG2 TUBG1 TUBGCP6	5.39e-04	21	161	3	GO:0000930
GeneOntologyCellularComponent	lamellipodium membrane	PLXND1 PLEK2 SYNE2	6.20e-04	22	161	3	GO:0031258
GeneOntologyCellularComponent	postsynaptic density	SHANK1 ATP7A PPP1R9A GRIN1 CLSTN1 CRHR1 SLC8A1 SHANK2 SIPA1L1 BAIAP2 NOS1	7.66e-04	451	161	11	GO:0014069
GeneOntologyCellularComponent	dendrite	SHANK1 ATP7A PPP1R9A GRIN1 CLSTN1 CRHR1 SLC8A1 SHANK2 SV2A SIPA1L1 MAST1 RABGEF1 KIF5C BAIAP2 NOS1 GABRA4	9.87e-04	858	161	16	GO:0030425
GeneOntologyCellularComponent	dendritic tree	SHANK1 ATP7A PPP1R9A GRIN1 CLSTN1 CRHR1 SLC8A1 SHANK2 SV2A SIPA1L1 MAST1 RABGEF1 KIF5C BAIAP2 NOS1 GABRA4	1.01e-03	860	161	16	GO:0097447
GeneOntologyCellularComponent	asymmetric synapse	SHANK1 ATP7A PPP1R9A GRIN1 CLSTN1 CRHR1 SLC8A1 SHANK2 SIPA1L1 BAIAP2 NOS1	1.21e-03	477	161	11	GO:0032279
GeneOntologyCellularComponent	postsynaptic membrane	SHANK1 ERBB2 COL13A1 GRIN1 CLSTN1 CRHR1 CHRND SLC8A1 SHANK2 GABRA4	1.21e-03	405	161	10	GO:0045211
GeneOntologyCellularComponent	leading edge membrane	ERBB2 EPS8L1 GRIN1 PLXND1 PLEK2 SYNE2 GABRA4	1.24e-03	210	161	7	GO:0031256
GeneOntologyCellularComponent	fibrillar center	RERG RREB1 UTP15 RPS6KA6 SMARCA4 PLRG1	1.34e-03	156	161	6	GO:0001650
HumanPheno	Abnormality of the shoulder girdle musculature	COL6A2 TBX3 COL13A1 MATR3 PLXND1 DYSF CHRND PTPN11 SYNE2	1.82e-05	149	53	9	HP:0001435
HumanPheno	Abnormal shoulder morphology	COL6A2 TBX3 COL13A1 ATP7A MATR3 PLXND1 DYSF CHRND PTPN11 SYNE2 TBL2	3.34e-05	246	53	11	HP:0003043
MousePheno	abnormal maternal behavior	SHANK1 ING1 CORT SPTA1 GRIN1 SHANK2 NEK8 NOS1	1.23e-05	115	131	8	MP:0008779
MousePheno	abnormal maternal nurturing	SHANK1 ING1 CORT SPTA1 GRIN1 SHANK2 NEK8	5.74e-05	105	131	7	MP:0001386
MousePheno	double outlet right ventricle	DNAAF4 MATR3 ERMP1 PLXND1 PTPN11 ADAMTS6 NEK8 SMARCA4	8.28e-05	150	131	8	MP:0000284
MousePheno	abnormal interventricular septum muscular part morphology	DNAAF4 MATR3 XPNPEP1 ADAMTS6 SMARCA4 BAIAP2	9.59e-05	79	131	6	MP:0010498
MousePheno	abnormal heart ventricle wall morphology	ERBB2 RREB1 ARHGEF17 ANKLE2 SLC8A1 PTPN11 PDLIM3 ADAMTS6 CTCF BAIAP2 NOS1	1.06e-04	296	131	11	MP:0031532
MousePheno	abnormal parental behavior	SHANK1 ING1 CORT SPTA1 GRIN1 SHANK2 NEK8 NOS1	1.30e-04	160	131	8	MP:0002068
MousePheno	atrioventricular septal defect	DNAAF4 PLXND1 PTPN11 ADAMTS6 NEK8 SMARCA4	1.35e-04	84	131	6	MP:0010412
MousePheno	abnormal heart ventricle morphology	TBX3 ERBB2 COL11A1 DNAAF4 MATR3 XPNPEP1 PLXND1 RREB1 ARHGEF17 ANKLE2 SLC8A1 PTPN11 PDLIM3 ADAMTS6 CTCF NEK8 SMARCA4 BAIAP2 NOS1	1.46e-04	793	131	19	MP:0005294
MousePheno	abnormal atrioventricular septum morphology	DNAAF4 PLXND1 PTPN11 ADAMTS6 NEK8 SMARCA4	1.64e-04	87	131	6	MP:0010592
Domain	SNF2_N	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	2.52e-07	32	158	6	IPR000330
Domain	SNF2_N	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	2.52e-07	32	158	6	PF00176
Domain	BRK	CHD8 SMARCA2 SMARCA4	1.17e-05	6	158	3	SM00592
Domain	BRK_domain	CHD8 SMARCA2 SMARCA4	1.17e-05	6	158	3	IPR006576
Domain	BRK	CHD8 SMARCA2 SMARCA4	1.17e-05	6	158	3	PF07533
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	7.11e-05	2	158	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	7.11e-05	2	158	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	7.11e-05	2	158	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	7.11e-05	2	158	2	PS51666
Domain	SnAC	SMARCA2 SMARCA4	7.11e-05	2	158	2	SM01314
Domain	SnAC	SMARCA2 SMARCA4	7.11e-05	2	158	2	IPR029295
Domain	QLQ	SMARCA2 SMARCA4	7.11e-05	2	158	2	PF08880
Domain	Gamma_tubulin	TUBG2 TUBG1	7.11e-05	2	158	2	IPR002454
Domain	PDZ	SHANK1 PPP1R9A SHANK2 PDLIM3 SIPA1L1 MAST1 NOS1	1.99e-04	141	158	7	PF00595
Domain	PDZ	SHANK1 PPP1R9A SHANK2 PDLIM3 SIPA1L1 MAST1 NOS1	2.68e-04	148	158	7	SM00228
Domain	-	SHANK1 PPP1R9A SHANK2 PDLIM3 SIPA1L1 MAST1 NOS1	2.91e-04	150	158	7	2.30.42.10
Domain	Helicase_C	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	2.98e-04	107	158	6	PF00271
Domain	HELICc	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	2.98e-04	107	158	6	SM00490
Domain	PDZ	SHANK1 PPP1R9A SHANK2 PDLIM3 SIPA1L1 MAST1 NOS1	3.03e-04	151	158	7	PS50106
Domain	Helicase_C	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	3.13e-04	108	158	6	IPR001650
Domain	PDZ	SHANK1 PPP1R9A SHANK2 PDLIM3 SIPA1L1 MAST1 NOS1	3.15e-04	152	158	7	IPR001478
Domain	HELICASE_CTER	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	3.29e-04	109	158	6	PS51194
Domain	HELICASE_ATP_BIND_1	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	3.29e-04	109	158	6	PS51192
Domain	DEXDc	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	3.29e-04	109	158	6	SM00487
Domain	Helicase_ATP-bd	TTF2 CHD8 CHD3 INO80 SMARCA2 SMARCA4	3.46e-04	110	158	6	IPR014001
Domain	HSA	SMARCA2 SMARCA4	4.22e-04	4	158	2	SM00573
Domain	HSA	SMARCA2 SMARCA4	4.22e-04	4	158	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	4.22e-04	4	158	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	4.22e-04	4	158	2	PF07529
Domain	SH3_2	SHANK1 MACC1 SHANK2 BAIAP2 MCF2L	8.16e-04	86	158	5	PF07653
Domain	SH3_2	SHANK1 MACC1 SHANK2 BAIAP2 MCF2L	8.16e-04	86	158	5	IPR011511
Domain	Spectrin	SPTA1 SYNE2 MCF2L	9.29e-04	23	158	3	PF00435
Domain	PH_dom-like	ARHGEF28 EPS8L1 PLEKHA6 EPB41L4A ARHGEF17 FARP2 PLEK2 MTMR3 ARHGAP25 MCF2L PLEKHA7	1.02e-03	426	158	11	IPR011993
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	COL6A2 ERBB2 ARHGEF28 COL6A6 SPTA1 DPYSL4 GRIN1 PLXND1 FARP2 PTPN11 PRKCQ	1.62e-05	261	122	11	MM15676
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHANK1 FKBP15 NES USP28 MATR3 PPP1R9A DPYSL4 CHD8 GRIN1 HUWE1 JAKMIP2 ITIH4 MDN1 SHANK2 UBR5 CTCF SIPA1L1 SYNE2 SMARCA4 RABGEF1 KIF5C BAIAP2 NOS1 UNC79 CEP170B GOLGA3 SH3BP5	1.00e-13	963	164	27	28671696
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	MUC16 CHD3 XPNPEP1 HUWE1 MDN1 NEK8 SYNE2 DECR2 UNC79 HYDIN	9.16e-09	170	164	10	23314748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 ERBB2 EMC1 USP28 CEP162 MATR3 CHD8 ERMP1 PLXND1 INO80 ANKLE2 CWC22 TUBGCP6 PPM1F ANKS3	3.67e-08	529	164	15	14621295
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 NES SPTA1 MATR3 PPP1R9A DPYSL4 CHD3 GRIN1 PLEKHA6 ARHGEF17 SHANK2 MYH14 SV2A SIPA1L1 SMARCA4 MAST1 KMT2A KIF5C BAIAP2 CROCC PLEKHA7 NOS1 CEP170B GOLGA3	7.18e-08	1431	164	24	37142655
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SMG1 FBLN7 ERBB2 MUC16 PTPN11 SHANK2 UTP15 PPM1F NEK8 MTMR3 RABGEF1 PLEKHA7 DNAH8	1.14e-07	420	164	13	28065597
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NES ERBB2 EMC1 ARHGEF28 TRPM7 CEP162 MATR3 ARHGEF17 MDN1 TESK2 SIPA1L1 SYNE2 KMT2A RABGEF1 KIF5C BAIAP2 PLEKHA7 CEP170B	1.52e-07	861	164	18	36931259
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MACC1 EMC1 ZNF652 PPP1R9A CHD8 ERMP1 INO80 FARP2 MED15 MDN1 SHANK2 UTP15 CTCF SIPA1L1 SMARCA2 MLH1 KMT2A DECR2 BAIAP2 CROCC PLEKHA7 TBL2 CEP170B STOM	1.64e-07	1497	164	24	31527615
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	MATR3 CHD8 CHD3 INO80 CWC22 MED15 MDN1 CTCF SMARCA2 SMARCA4 NLRC5 KMT2A BAIAP2 CROCC	2.69e-07	533	164	14	30554943
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TBX3 ERBB2 CHD8 CHD3 INO80 RREB1 TUBG1 ITIH4 TUBGCP6 THADA UBR5 CTCF SV2A SIPA1L1 SMARCA2 MLH1 SMARCA4 ANKS3 CEP170B WDTC1	3.48e-07	1116	164	20	31753913
Pubmed	Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.	SHANK1 GRIN1 SHANK2 BAIAP2	4.60e-07	14	164	4	21795692
Pubmed	The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis.	NES TUBG2 TUBG1	1.02e-06	5	164	3	21529752
Pubmed	WDR62 is associated with the spindle pole and is mutated in human microcephaly.	NES TUBG2 TUBG1	1.02e-06	5	164	3	20890279
Pubmed	The insulin receptor substrate IRSp53 links postsynaptic shank1 to the small G-protein cdc42.	SHANK1 SHANK2 BAIAP2	1.02e-06	5	164	3	12504591
Pubmed	Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95.	SHANK1 GRIN1 BAIAP2	1.02e-06	5	164	3	15255944
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	COL6A2 PRTG ERBB2 COL13A1 ZNF652 CYBC1 CC2D1B CHD8 ERMP1 WAC TUBGCP6 TLNRD1 PTPN11 VPS13A MLH1 RABGEF1 PLEKHA7 CEP170B CAVIN2 SH3BP5	1.30e-06	1215	164	20	15146197
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	FKBP15 IPO7 USP28 MATR3 CHD8 CHD3 PSME2 INO80 MED15 GTF2E1 PTPN11 MDN1 UBR5 CTCF SMARCA2 SMARCA4 KMT2A PLRG1	1.60e-06	1014	164	18	32416067
Pubmed	CROCCP2 acts as a human-specific modifier of cilia dynamics and mTOR signaling to promote expansion of cortical progenitors.	TUBG2 TUBG1 CROCC	2.04e-06	6	164	3	36334595
Pubmed	DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis.	NES TUBG2 TUBG1	2.04e-06	6	164	3	22842144
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SMG1 COL6A2 TBX3 EMC1 ARHGEF28 CC2D1B CHD8 CHD3 CLSTN1 CWC22 FARP2 MLH1 KMT2A PLRG1	2.79e-06	650	164	14	38777146
Pubmed	Defining the membrane proteome of NK cells.	DCAKD FKBP15 ATP7A IPO7 MATR3 AGPAT3 ERMP1 PSME2 HUWE1 ANKLE2 MED15 TUBGCP6 MDN1 UBR5 MYH14 MLH1 SMARCA4 GOLGA3 STOM	2.89e-06	1168	164	19	19946888
Pubmed	HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis.	TUBG2 TUBG1 UBR5	3.55e-06	7	164	3	29724823
Pubmed	Asymmetric segregation of the double-stranded RNA binding protein Staufen2 during mammalian neural stem cell divisions promotes lineage progression.	NES TUBG2 TUBG1	3.55e-06	7	164	3	22902295
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FKBP15 PPP1R9A ARHGEF17 UBR5 SV2A SIPA1L1 MTMR3 MAST1 MCF2L CROCC CEP170B	4.09e-06	407	164	11	12693553
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	DCAKD FKBP15 DNAAF4 AGPAT3 PPP1R11 RREB1 ANKLE2 TUBG1 MED15 THADA NEK8 TESK2 SIPA1L1 RABGEF1 KIF5C BAIAP2 PLEKHA7 ANKS3 STOM WDTC1	4.57e-06	1321	164	20	27173435
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ERBB2 MYOM3 CHD8 PLXND1 INO80 HUWE1 DYSF TUBG1 TLNRD1 THADA TKFC MDN1 SHANK2 NEK8 MTMR3 NLRC5 MCF2L CEP170B	5.27e-06	1105	164	18	35748872
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ING1 USP28 CHD8 CHD3 WAC MED15 SMARCA2 SMARCA4 KMT2A	5.60e-06	268	164	9	33640491
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAKD ERBB2 PPP1R9A AGPAT3 CHD3 HUWE1 FARP2 THADA USF3 SHANK2 MYH14 SMARCA2 NLRC5 MAST1 KIF5C BAIAP2 MCF2L CROCC POLK ZMAT1 CEP170B	7.68e-06	1489	164	21	28611215
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	DNAAF4 ERMP1 PLXND1 ADAMTS6 NEK8 SMARCA4	8.29e-06	100	164	6	25807483
Pubmed	Direct binding of NuMA to tubulin is mediated by a novel sequence motif in the tail domain that bundles and stabilizes microtubules.	TUBG2 TUBG1 TUBGCP6	8.47e-06	9	164	3	11956313
Pubmed	Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis.	TUBG2 TUBG1 TUBGCP6	8.47e-06	9	164	3	8838651
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	SMG1 DDAH2 ERBB2 EMC1 ATP7A PPP1R9A AGPAT3 PLEKHA6 THADA SHANK2 UBR5 BAIAP2 PLEKHA7 CAVIN2	8.77e-06	719	164	14	35337019
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CEP162 ZNF652 PLEKHA6 SYNE2 VPS13A MAST1	9.29e-06	102	164	6	10231032
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TTF2 FKBP15 CEP162 PPP1R9A UBR5 SIPA1L1 MTMR3 RABGEF1 BAIAP2 PLEKHA7 CEP170B	9.67e-06	446	164	11	24255178
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TTF2 FKBP15 USP28 MATR3 DPYSL4 CHD3 PSME2 WAC GTF2E1 PTPN11 PDLIM3 CTCF MLH1 SMARCA4 KMT2A PLRG1	9.77e-06	934	164	16	33916271
Pubmed	The functional interactome landscape of the human histone deacetylase family.	TTF2 ING1 CHD3 HUWE1 RREB1 MDN1 UBR5 SYNE2 CROCC	1.03e-05	289	164	9	23752268
Pubmed	The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity.	SHANK1 GRIN1 SHANK2 BAIAP2	1.03e-05	29	164	4	19208628
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DCAKD EMC1 IPO7 CEP162 PPP1R9A PPP1R11 HUWE1 ANKLE2 GTF2E1 PTPN11 PPM1F SYNE2 VPS13A MTMR3 MLH1 BAIAP2 PLEKHA7	1.04e-05	1049	164	17	27880917
Pubmed	A protein interaction landscape of breast cancer.	TBX3 ERBB2 USP28 MDN1 UBR5 CTCF SMARCA2 MLH1 SMARCA4 PLEKHA7 TBL2 CAVIN2 STOM	1.08e-05	634	164	13	34591612
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SMG1 IPO7 MUC16 MED15 MDN1 ADAMTS6 PPM1F SYNE2 VPS13A SMARCA2 MCF2L TBL2 CAVIN2	1.15e-05	638	164	13	31182584
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NES IPO7 CHD8 HUWE1 MDN1 UBR5 UTP15 CTCF MYH14 SYNE2 SMARCA2 SMARCA4 KMT2A	1.47e-05	653	164	13	22586326
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	IPO7 ING1 CHD8 CHD3 HUWE1 DNAAF8 SMARCA4 KMT2A UNC79 PLRG1 HYDIN	1.54e-05	469	164	11	27634302
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 MACC1 SPTA1 MATR3 PPP1R9A CC2D1B CHD3 ANKLE2 PLEK2 C4orf17 MDN1 SHANK2 MYH14 SYNE2 VPS13A KMT2A KIF5C MCF2L DNAH8 CAVIN2	1.64e-05	1442	164	20	35575683
Pubmed	Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.	CHD3 SMARCA2 SMARCA4	1.65e-05	11	164	3	10204490
Pubmed	The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.	NES TUBG2 TUBG1	1.65e-05	11	164	3	18364031
Pubmed	Gradual centriole maturation associates with the mitotic surveillance pathway in mouse development.	TUBG2 USP28 TUBG1	1.65e-05	11	164	3	33410253
Pubmed	An RNA-binding protein, Qki5, regulates embryonic neural stem cells through pre-mRNA processing in cell adhesion signaling.	NES TUBG2 TUBG1	1.65e-05	11	164	3	29021239
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TTF2 IPO7 CCDC174 ZNF652 CHD8 CHD3 PSME2 RREB1 TUBG1 PRDM2 WAC MED15 UBR5 SMARCA2 SMARCA4 KMT2A PLRG1	1.98e-05	1103	164	17	34189442
Pubmed	Novel embryonic neuronal migration and proliferation defects in Dcx mutant mice are exacerbated by Lis1 reduction.	NES TUBG2 TUBG1	2.20e-05	12	164	3	20181597
Pubmed	Augmin deficiency in neural stem cells causes p53-dependent apoptosis and aborts brain development.	NES TUBG2 TUBG1	2.20e-05	12	164	3	34427181
Pubmed	Talpid3-Mediated Centrosome Integrity Restrains Neural Progenitor Delamination to Sustain Neurogenesis by Stabilizing Adherens Junctions.	NES TUBG2 TUBG1	2.20e-05	12	164	3	33326788
Pubmed	Recapitulation of two genomewide association studies on blood pressure and essential hypertension in the Korean population.	TBX3 ZNF652 PLEKHA7	2.20e-05	12	164	3	20414254
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	2.21e-05	2	164	2	8670841
Pubmed	Differential expression of alternatively spliced isoforms of neuronal nitric oxide synthase (nNOS) and N-methyl-D-aspartate receptors (NMDAR) in knockout mice deficient in nNOS alpha (nNOS alpha(Delta/Delta) mice).	GRIN1 NOS1	2.21e-05	2	164	2	11146102
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	2.21e-05	2	164	2	23163725
Pubmed	Decreased phosphorylation of δ and ε subunits of the acetylcholine receptor coincides with delayed postsynaptic maturation in PKC θ deficient mouse.	CHRND PRKCQ	2.21e-05	2	164	2	20599977
Pubmed	CTCF-dependent chromatin insulator is linked to epigenetic remodeling.	CHD8 CTCF	2.21e-05	2	164	2	16949368
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	2.21e-05	2	164	2	23076393
Pubmed	Genetic associations in PLEKHA7 and COL11A1 with primary angle closure glaucoma: a meta-analysis.	COL11A1 PLEKHA7	2.21e-05	2	164	2	25732101
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	2.21e-05	2	164	2	15576411
Pubmed	Molecular mechanism for SHP2 in promoting HER2-induced signaling and transformation.	ERBB2 PTPN11	2.21e-05	2	164	2	19261604
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	2.21e-05	2	164	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	2.21e-05	2	164	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	2.21e-05	2	164	2	33027072
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	2.21e-05	2	164	2	23872584
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	2.21e-05	2	164	2	23088494
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	2.21e-05	2	164	2	20333683
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	2.21e-05	2	164	2	34812766
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	2.21e-05	2	164	2	30478150
Pubmed	MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages.	TUBG2 TUBG1	2.21e-05	2	164	2	17442887
Pubmed	Association of ADHD and the Protogenin gene in the chromosome 15q21.3 reading disabilities linkage region.	PRTG DNAAF4	2.21e-05	2	164	2	19076634
Pubmed	Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.	CTCF KMT2A	2.21e-05	2	164	2	34405474
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	2.21e-05	2	164	2	25808524
Pubmed	Overexpression of γ-tubulin in non-small cell lung cancer.	TUBG2 TUBG1	2.21e-05	2	164	2	22806905
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	2.21e-05	2	164	2	19144648
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	2.21e-05	2	164	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	2.21e-05	2	164	2	37634210
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	2.21e-05	2	164	2	8208605
Pubmed	Allocation of gamma-tubulin between oocyte cortex and meiotic spindle influences asymmetric cytokinesis in the mouse oocyte.	TUBG2 TUBG1	2.21e-05	2	164	2	17287496
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	2.21e-05	2	164	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	2.21e-05	2	164	2	12620226
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	2.21e-05	2	164	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	2.21e-05	2	164	2	29848589
Pubmed	Disruption of a -35 kb Enhancer Impairs CTCF Binding and MLH1 Expression in Colorectal Cells.	CTCF MLH1	2.21e-05	2	164	2	29898989
Pubmed	Differential expression of human γ-tubulin isotypes during neuronal development and oxidative stress points to a γ-tubulin-2 prosurvival function.	TUBG2 TUBG1	2.21e-05	2	164	2	28119396
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	2.21e-05	2	164	2	9603422
Pubmed	[NMDA receptor and NOS in morphine tolerance in mice with bone cancer].	GRIN1 NOS1	2.21e-05	2	164	2	20543469
Pubmed	Extended association study of PLEKHA7 and COL11A1 with primary angle closure glaucoma in a Han Chinese population.	COL11A1 PLEKHA7	2.21e-05	2	164	2	24854855
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	2.21e-05	2	164	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	2.21e-05	2	164	2	27097303
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	2.21e-05	2	164	2	28038711
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	2.21e-05	2	164	2	23963727
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	2.21e-05	2	164	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	2.21e-05	2	164	2	31375262
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	2.21e-05	2	164	2	17075831
Pubmed	USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.	USP28 MAST1	2.21e-05	2	164	2	38498222
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	2.21e-05	2	164	2	32855269
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	2.21e-05	2	164	2	22721696
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	2.21e-05	2	164	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	2.21e-05	2	164	2	11719516
Pubmed	Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.	SHANK1 SHANK2	2.21e-05	2	164	2	25188300
Interaction	TNIK interactions	SHANK1 FKBP15 NES MATR3 CHD8 GRIN1 HUWE1 SHANK2 SIPA1L1 SYNE2 KIF5C BAIAP2 NOS1 CEP170B	2.58e-06	381	162	14	int:TNIK
Cytoband	Xq21	RPS6KA6 ZMAT1	7.57e-05	4	164	2	Xq21
GeneFamily	PDZ domain containing	SHANK1 PPP1R9A SHANK2 PDLIM3 SIPA1L1 MAST1 NOS1	3.76e-05	152	109	7	1220
GeneFamily	Collagens	COL6A2 COL11A1 COL13A1 COL6A6	1.68e-04	46	109	4	490
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	FKBP15 COL11A1 COL6A6 PPP1R9A NUTM2A PGM2L1 CHD3 PLEKHA6 PRDM2 SLC8A1 MDN1 SHANK2 SV2A MAST1 C2CD6 KIF5C MCF2L UNC79 ZMAT1 HYDIN GOLGA3 SH3BP5 ZNF697	4.40e-07	1106	164	23	M39071
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_DN	MATR3 ANKLE2 FAH UBR5 SIPA1L1 MROH7 KMT2A PRKCQ MCF2L STOM	1.11e-05	279	164	10	M16867
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMG1 ERBB2 MACC1 MUC16 EPS8L1 ANKLE2 CAPN8 MYH14 MCF2L	2.27e-08	179	164	9	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL11A1 ARHGEF28 PPP1R9A SHANK2 ADAMTS6 MYO3B PRKCQ KIF5C ZMAT1	3.32e-08	187	164	9	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	IQANK1 MACC1 ARHGEF28 NEUROD4 PPP1R9A SHANK2 MYH14 KIF5C	4.26e-07	184	164	8	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 SYNE2 PRKCQ BAIAP2 PLEKHA7	4.81e-07	187	164	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MACC1 ARHGEF28 PPP1R9A SHANK2 MYH14 MYO3B KIF5C ZMAT1	5.22e-07	189	164	8	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MACC1 ARHGEF28 PPP1R9A MUC16 CAPN8 SHANK2 MYH14 PLEKHA7	5.43e-07	190	164	8	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 ARHGEF28 PPP1R9A PLEKHA6 EPB41L4A SHANK2 SYNE2 PLEKHA7	6.36e-07	194	164	8	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	COL6A2 CHD3 JAKMIP2 SYNE2 NLRC5 ARHGAP25 PRKCQ STOM	6.87e-07	196	164	8	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NES COL6A2 RERG TBX3 DPYSL4 ARHGEF17 JAKMIP2 ZNF697	7.14e-07	197	164	8	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 PPP1R9A PLEKHA6 SHANK2 MYO3B SYNE2 PLEKHA7 HYDIN	7.14e-07	197	164	8	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPS8L1 SHANK2 MYH14 SYNE2 SMARCA4 BAIAP2 PLEKHA7 ZMAT1	7.14e-07	197	164	8	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NES COL6A2 RERG TBX3 DPYSL4 ARHGEF17 JAKMIP2 ZNF697	7.14e-07	197	164	8	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ERBB2 MACC1 EPS8L1 SHANK2 MYH14 SYNE2 BAIAP2 CAVIN2	7.70e-07	199	164	8	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CORT PLXND1 DYSF PPM1F MCF2L CAVIN2 STOM SH3BP5	8.00e-07	200	164	8	ae6cc5462a8a254682793fb8cc348b9721c729bf
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	ERBB2 EPS8L1 SHANK2 MYH14 SYNE2 BAIAP2 CEP170B CAVIN2	8.00e-07	200	164	8	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ERBB2 EPS8L1 SHANK2 MYH14 SYNE2 SMARCA4 BAIAP2 CAVIN2	8.00e-07	200	164	8	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGEF28 PPP1R9A MUC16 EPB41L4A CAPN8 SHANK2 MCF2L PLEKHA7	8.00e-07	200	164	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ERBB2 EPS8L1 SHANK2 MYH14 SYNE2 SMARCA4 BAIAP2 CAVIN2	8.00e-07	200	164	8	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NES PLXND1 DYSF ADAMTS6 PPM1F CAVIN2 STOM SH3BP5	8.00e-07	200	164	8	2e47888e041ec3d265425d1df97b6665c6da889c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NES PLXND1 DYSF ADAMTS6 PPM1F CAVIN2 STOM SH3BP5	8.00e-07	200	164	8	50fa0f8a3e490d5941b34e66a10158eba6c909d4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NES TBX3 PLXND1 DYSF TLNRD1 PPM1F CAVIN2 SH3BP5	8.00e-07	200	164	8	ced14d83222dbebca85c40540e76824e683354f3
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF28 SHANK2 MYH14 SYNE2 PRKCQ BAIAP2 PLEKHA7	4.61e-06	179	164	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Pericytes-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	COL6A2 RERG COL13A1 CCDC168 PDLIM3 SV2A KIF5C	5.33e-06	183	164	7	d04deef7cd4e1738227a6593b84874ce0168c773
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MACC1 ARHGEF28 PLEKHA6 SHANK2 SYNE2 PLEKHA7 HYDIN	5.33e-06	183	164	7	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 SHANK2 MYH14 SYNE2 BAIAP2 PLEKHA7 CAVIN2	5.53e-06	184	164	7	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MACC1 COL11A1 ARHGEF28 PPP1R9A SHANK2 PRKCQ KIF5C	5.93e-06	186	164	7	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ BAIAP2 PLEKHA7	5.93e-06	186	164	7	e83718fabb057100835d3357df407f283d23fe16
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	NES TBX3 EPB41L4A DYSF ADAMTS6 MCF2L SH3BP5	7.55e-06	193	164	7	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBX3 PPP1R9A EPB41L4A DYSF SMARCA2 MCF2L SH3BP5	7.55e-06	193	164	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 ARHGEF28 PPP1R9A SHANK2 MYO3B PLEKHA7 HYDIN	7.81e-06	194	164	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLXND1 EPB41L4A TLNRD1 ADAMTS6 MCF2L STOM SH3BP5	7.81e-06	194	164	7	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MACC1 COL11A1 ARHGEF28 PPP1R9A SHANK2 MYO3B KIF5C	8.08e-06	195	164	7	98dd3b7d5ef587825dac052dea4d4ff883f6d4d6
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MACC1 COL11A1 ARHGEF28 PPP1R9A SHANK2 MYO3B KIF5C	8.08e-06	195	164	7	ce1ba5911e8a6ddb07434acc37147c38e94245ff
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 ARHGEF28 PPP1R9A CAPN8 SHANK2 MYO3B PLEKHA7	8.35e-06	196	164	7	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	PCW_10-12-Epithelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MACC1 COL11A1 ARHGEF28 PPP1R9A SHANK2 MYO3B KIF5C	8.35e-06	196	164	7	9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 RERG FBLN7 COL13A1 PDLIM3 RPS6KA6 FZD10	8.35e-06	196	164	7	614a07334707eafe238d5cb7b080a3ca796a1920
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 ARHGEF28 PPP1R9A SHANK2 MYO3B PLEKHA7 HYDIN	8.35e-06	196	164	7	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 CHD3 SYNE2 VPS13A SMARCA2 KMT2A PRKCQ	8.63e-06	197	164	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer\|World / Primary Cells by Cluster	PGM2L1 CHD3 PLXND1 CLSTN1 SMARCA4 KIF5C SH3BP5	8.63e-06	197	164	7	41e823b14697827f657b13adb3afa581bd91a9cb
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	TBX3 EPB41L4A DYSF ADAMTS6 SYNE2 MCF2L SH3BP5	8.63e-06	197	164	7	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	USP28 CHD3 JAKMIP2 SYNE2 ARHGAP25 PRKCQ STOM	8.63e-06	197	164	7	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAAF4 EPS8L1 JAKMIP2 FHAD1 KIF5C CFAP44 HYDIN	8.92e-06	198	164	7	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAAF4 EPS8L1 JAKMIP2 FHAD1 KIF5C CFAP44 HYDIN	8.92e-06	198	164	7	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	NES TBX3 EPB41L4A ADAMTS6 SYNE2 MCF2L SH3BP5	9.22e-06	199	164	7	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	343B-Endothelial_cells-Endothelial-E-\|343B / Donor, Lineage, Cell class and subclass (all cells)	NES TBX3 DYSF ADAMTS6 MCF2L CAVIN2 SH3BP5	9.22e-06	199	164	7	bff61a784ef8bc040f5c7baabccaf7a7cddd5a31
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ERBB2 EPS8L1 SHANK2 MYH14 SYNE2 BAIAP2 CAVIN2	9.22e-06	199	164	7	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 DYSF PPM1F SYNE2 CAVIN2 STOM SH3BP5	9.22e-06	199	164	7	14e09eaa2335d4503de50250eb4258dd5b85b304
ToppCell	343B-Endothelial_cells-Endothelial-E\|343B / Donor, Lineage, Cell class and subclass (all cells)	NES TBX3 DYSF ADAMTS6 MCF2L CAVIN2 SH3BP5	9.22e-06	199	164	7	3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac
ToppCell	Kidney-Endothelial\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	NES PLXND1 DYSF PPM1F CAVIN2 STOM SH3BP5	9.22e-06	199	164	7	b543f0686522df43737e9ffa5c9733e42b8a9f4d
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PPP1R9A EPB41L4A UBR5 SYNE2 KMT2A MCF2L SH3BP5	9.53e-06	200	164	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 COL6A2 USP28 JAKMIP2 SYNE2 KMT2A N4BP1	9.53e-06	200	164	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NES PLXND1 DYSF ADAMTS6 CAVIN2 STOM SH3BP5	9.53e-06	200	164	7	dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NES PLXND1 DYSF ADAMTS6 CAVIN2 STOM SH3BP5	9.53e-06	200	164	7	7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGEF28 PPP1R9A MUC16 CAPN8 SHANK2 MCF2L PLEKHA7	9.53e-06	200	164	7	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP7A COL6A6 FARP2 MED15 C2CD6 GOLGA3	2.39e-05	155	164	6	441fcb6d05364fc6f4973f0b973f1a80b573ce1f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ATP7A MYOM3 C4orf17 SYNE2 PRKCQ MCF2L	2.96e-05	161	164	6	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	mild_COVID-19_(asymptomatic)-B_intermediate\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	MACC1 MATR3 EPB41L4A PRDM2 ARHGAP25 DNAH8	3.51e-05	166	164	6	8de8f388f24436b84e19ef460476fdbda4d16abf
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MACC1 MUC16 CHD3 EPS8L1 CAPN8 MYH14	3.88e-05	169	164	6	40b557549fe08c5dc9dba359af35993d68d1640a
ToppCell	T_cells-GNLY+GZMB+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	USP28 CAPN8 FHAD1 MYH14 MYO3B ARHGAP25	4.14e-05	171	164	6	04c811817cfec45af5f2891793106cc7ddb0300e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF4 C2orf81 RPS6KA6 CROCC CFAP44 HYDIN	4.42e-05	173	164	6	a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN7 CORT AGPAT3 DNAH8 GPANK1 TBL2	4.42e-05	173	164	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN7 CORT AGPAT3 DNAH8 GPANK1 TBL2	4.42e-05	173	164	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF4 C2orf81 RPS6KA6 CROCC CFAP44 HYDIN	4.42e-05	173	164	6	e3e3a67a5a93ef4475224a256d45ae24526383cc
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYSF PDLIM3 MYO3B CAVIN2 STOM SH3BP5	4.42e-05	173	164	6	b57d14e2c2368304cb903562d06ce8228f53857c
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL11A1 COL6A6 MUC16 GDF2 SYNE2 KIF5C	4.56e-05	174	164	6	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	(1)_T_regulatory\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	FBLN7 PGM2L1 RAB33A THADA SYNE2 DNAH8	5.02e-05	177	164	6	5cda56b10df1ee8971ce8470d52062e01b703a4e
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1\|TCGA-Liver / Sample_Type by Project: Shred V9	COL11A1 COL13A1 DNAAF4 EPS8L1 EPB41L4A C2orf81	5.18e-05	178	164	6	51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RERG ARHGEF28 PLEKHA6 SHANK2 SYNE2 HYDIN	5.18e-05	178	164	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	droplet-Fat-Gat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTG CCDC174 DYSF TUBGCP6 MCF2L SH3BP5	5.34e-05	179	164	6	08cf9986804a6417a9afb19b50c69a3554f71ec6
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLXND1 DYSF TLNRD1 PPM1F MCF2L CAVIN2	5.51e-05	180	164	6	97e0dcb7cfbba60a782824c5e23995058609fcd4
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TBX3 PLXND1 EPB41L4A DYSF TLNRD1 SH3BP5	5.51e-05	180	164	6	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ BAIAP2	5.68e-05	181	164	6	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	TBX3 EPB41L4A ADAMTS6 SYNE2 MCF2L CAVIN2	5.68e-05	181	164	6	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	Pericytes-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	COL6A2 RERG TBX3 DPYSL4 PDLIM3 FZD10	5.68e-05	181	164	6	ff445a8e56522e57e27405184d123cf905caf8cc
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES PLXND1 TUBG1 TLNRD1 PPM1F CAVIN2	5.68e-05	181	164	6	4a225d9a6d113396c6b1d0a839bb4ca9c339a260
ToppCell	NS-moderate-d_16-33-Lymphoid-NK\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NES COL6A2 TBX3 PRTG PDLIM3 NOS1	5.86e-05	182	164	6	fb503f8ecd013f1f2161a5841572b57cfcddb6fa
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	ARHGEF28 MUC16 PLEKHA6 CAPN8 MYH14 MXD1	6.04e-05	183	164	6	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NES PLXND1 MCF2L CAVIN2 STOM SH3BP5	6.04e-05	183	164	6	a644258ba90acc62d571623e429d72ffc4b69203
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERBB2 MACC1 SHANK2 MYH14 BAIAP2 PLEKHA7	6.04e-05	183	164	6	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLXND1 EPB41L4A ADAMTS6 MCF2L CAVIN2 SH3BP5	6.04e-05	183	164	6	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ BAIAP2	6.04e-05	183	164	6	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ATP8B3 NES PLXND1 DYSF PPM1F CAVIN2	6.22e-05	184	164	6	fa38d6a8709f520a027ad7e3ff783c84187ec467
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 SPTA1 CAPN8 SLC8A1 UNC79 HYDIN	6.22e-05	184	164	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IPO7 EPB41L4A DYSF PTPN11 N4BP1 SH3BP5	6.22e-05	184	164	6	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A2 RERG COL6A6 ARHGEF17 FHAD1 SLC8A1	6.22e-05	184	164	6	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 SPTA1 CAPN8 SLC8A1 UNC79 HYDIN	6.22e-05	184	164	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 SPTA1 CAPN8 SLC8A1 UNC79 HYDIN	6.22e-05	184	164	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ BAIAP2	6.22e-05	184	164	6	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	ARHGEF28 MUC16 EPS8L1 PLEKHA6 CAPN8 MYH14	6.22e-05	184	164	6	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ATP8B3 TBX3 NEUROD4 EPS8L1 MAST1 KIF5C	6.41e-05	185	164	6	ef996f4cdbc3971c6c0460d13df64b075ab22154
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ PLEKHA7	6.41e-05	185	164	6	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RREB1 NEU2 NEK8 CFAP44 PLEKHA7 HYDIN	6.41e-05	185	164	6	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ATP8B3 TBX3 NEUROD4 EPS8L1 MAST1 KIF5C	6.41e-05	185	164	6	d51342a3979bd728a80e04126059a3fd8a0dbe3b
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ERBB2 PPP1R9A CAPN8 SHANK2 MYH14 PLEKHA7	6.41e-05	185	164	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NES COL6A2 TBX3 PRTG COL13A1 PDLIM3	6.41e-05	185	164	6	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 BAIAP2 PLEKHA7	6.61e-05	186	164	6	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ PLEKHA7	6.61e-05	186	164	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SHANK1 PGM2L1 GRIN1 CLSTN1 MAST1 UNC79	6.61e-05	186	164	6	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MACC1 COL11A1 ARHGEF28 PPP1R9A SHANK2 KIF5C	6.80e-05	187	164	6	c2940aec30b3c2c113f6a65126dc6f1969cf301e
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 ARHGEF28 SHANK2 MYH14 PRKCQ BAIAP2	6.80e-05	187	164	6	201ff693e4756ee3e44762885b3a303a77eb535b
Disease	Todd Paralysis	ATP7A TRPM7 CHRND	1.28e-05	9	160	3	C0234544
Disease	Paralysed	ATP7A TRPM7 CHRND	1.28e-05	9	160	3	C0522224
Disease	complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology)	TUBG2 TUBG1	2.92e-05	2	160	2	DOID:0090138 (implicated_via_orthology)
Disease	reticulocyte count	ARHGEF28 SPTA1 PEX12 RREB1 PLEK2 THADA PTPN11 DCAF10 NEK8 TESK2 SYNE2 VPS13A MTMR3 MAST1 PCBD1 PLEKHA7 MXD1	5.66e-05	1045	160	17	EFO_0007986
Disease	level of Sphingomyelin (d32:1) in blood serum	ERMP1 SYNE2 SMARCA4	1.01e-04	17	160	3	OBA_2045173
Disease	Infiltrating duct carcinoma of female breast	SMG1 TRPM7 TESK2	1.94e-04	21	160	3	C3165106
Disease	activities of daily living score measurement	FARP2 FZD10 NOS1	1.94e-04	21	160	3	EFO_0008451
Disease	factor VII measurement	PRTG PRKCQ MCF2L TBL2	2.29e-04	55	160	4	EFO_0004619
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	FARP2 MCF2L PLRG1 TBL2	2.46e-04	56	160	4	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	2.89e-04	5	160	2	C3281201
Disease	transient cerebral ischemia (implicated_via_orthology)	PPP1R9A PLXND1 KMT2A NOS1	4.11e-04	64	160	4	DOID:224 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of ovary	ERBB2 MLH1 SMARCA4	5.15e-04	29	160	3	C0496920
Disease	Prostatic Neoplasms	TBX3 ERBB2 USP28 CHD3 WAC PLEK2 CTCF MYH14 MLH1 KMT2A POLK	5.66e-04	616	160	11	C0033578
Disease	Ovarian Carcinoma	ERBB2 MLH1 SMARCA4	5.70e-04	30	160	3	C0029925
Disease	palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement	SYNE2 SMARCA4	6.03e-04	7	160	2	EFO_0800400
Disease	Angle Closure Glaucoma	COL11A1 PLEKHA7	6.03e-04	7	160	2	C0017605
Disease	alcohol use disorder (implicated_via_orthology)	ERBB2 EPS8L1 CHRND SMARCA2 SMARCA4 UNC79	7.04e-04	195	160	6	DOID:1574 (implicated_via_orthology)
Disease	female breast cancer (is_implicated_in)	CTCF MAST1	8.01e-04	8	160	2	DOID:0050671 (is_implicated_in)
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	1.03e-03	9	160	2	DOID:0050340 (implicated_via_orthology)
Disease	spinal muscular atrophy (implicated_via_orthology)	ATP7A KIF5C	1.03e-03	9	160	2	DOID:12377 (implicated_via_orthology)
Disease	thoracic aortic calcification measurement	COL6A6 VPS13A	1.03e-03	9	160	2	EFO_0010273
Disease	primary angle closure glaucoma	COL11A1 PLEKHA7	1.56e-03	11	160	2	EFO_1001506
Disease	Macrocephaly	CHD8 CHD3	1.56e-03	11	160	2	C0221355
Disease	age at menarche	IQANK1 COL11A1 ADCK1 ERMP1 INO80 PRDM2 PPM1F SMARCA2 PLEKHA7 UNC79	1.56e-03	594	160	10	EFO_0004703
Disease	reticulocyte measurement	ARHGEF28 SPTA1 PEX12 RREB1 PLEK2 NEK8 TESK2 SYNE2 VPS13A MTMR3 MAST1 ARHGAP25 PLEKHA7 MXD1	1.84e-03	1053	160	14	EFO_0010700
Disease	Adenocarcinoma of large intestine	ERBB2 UBR5 MLH1 PRKCQ	1.88e-03	96	160	4	C1319315
Disease	fibrinogen measurement, tissue plasminogen activator measurement	PLXND1 FARP2 PLRG1	1.88e-03	45	160	3	EFO_0004623, EFO_0004791
Disease	Malignant neoplasm of prostate	TBX3 ERBB2 USP28 CHD3 WAC PLEK2 MYH14 MLH1 KMT2A POLK	2.03e-03	616	160	10	C0376358
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	2.19e-03	13	160	2	C0265338
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	CWC22 SMARCA2 KMT2A KIF5C	2.26e-03	101	160	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	Malformations of Cortical Development	TUBG1 KIF5C	2.55e-03	14	160	2	C1955869
Disease	triacylglycerol 46:2 measurement	JAKMIP2 MYO3B	2.55e-03	14	160	2	EFO_0010402
Disease	Cortical Dysplasia	TUBG1 KIF5C	2.55e-03	14	160	2	C0431380
Disease	asthma	ERBB2 ZNF652 MUC16 ERMP1 DYSF SLC8A1 SMARCA2 MROH7 PRKCQ UNC79 GPANK1	2.73e-03	751	160	11	MONDO_0004979
Disease	triacylglycerol 46:0 measurement	CWC22 JAKMIP2	2.93e-03	15	160	2	EFO_0010400
Disease	osteoarthritis (implicated_via_orthology)	COL11A1 ATP7A	2.93e-03	15	160	2	DOID:8398 (implicated_via_orthology)
Disease	Tremor, Rubral	ATP7A GABRA4	3.34e-03	16	160	2	C0750940
Disease	Ataxia, Appendicular	ATP7A GABRA4	3.34e-03	16	160	2	C0750937
Disease	Myasthenic Syndromes, Congenital, Slow Channel	COL13A1 CHRND	3.34e-03	16	160	2	C0751885
Disease	Ataxia, Motor	ATP7A GABRA4	3.34e-03	16	160	2	C0278161
Disease	Ataxia, Sensory	ATP7A GABRA4	3.34e-03	16	160	2	C0240991
Disease	Abnormal coordination	ATP7A GABRA4	3.34e-03	16	160	2	C0520966
Disease	Ataxia, Truncal	ATP7A GABRA4	3.34e-03	16	160	2	C0427190
Disease	prostate specific antigen measurement	SHANK1 TBX3 CHD3 DYSF THADA	3.69e-03	188	160	5	EFO_0004624
Disease	Benign neoplasm of stomach	ERBB2 UBR5	3.77e-03	17	160	2	C0153943
Disease	Congenital Myasthenic Syndromes, Postsynaptic	COL13A1 CHRND	3.77e-03	17	160	2	C0751883
Disease	Neoplasm of uncertain or unknown behavior of stomach	ERBB2 UBR5	3.77e-03	17	160	2	C0496905
Disease	Carcinoma in situ of stomach	ERBB2 UBR5	3.77e-03	17	160	2	C0154060
Disease	sphingomyelin 14:0 measurement	THADA SYNE2	3.77e-03	17	160	2	EFO_0010390
Disease	Cocaine-Related Disorders	GRIN1 CRHR1 SMARCA4 DNAH8	3.84e-03	117	160	4	C0236736
Disease	Congenital Myasthenic Syndromes, Presynaptic	COL13A1 CHRND	4.70e-03	19	160	2	C0751884
Disease	Central precocious puberty	PLEKHA8P1 PRKCQ	4.70e-03	19	160	2	EFO_0009029
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 MLH1	4.70e-03	19	160	2	DOID:2876 (is_marker_for)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	MLH1 SMARCA4	4.70e-03	19	160	2	C1333991
Disease	Cocaine Abuse	GRIN1 CRHR1 SMARCA4 DNAH8	5.13e-03	127	160	4	C0009171
Disease	Osteoarthritis of hip	COL11A1 CRHR1	5.21e-03	20	160	2	C0029410
Disease	Sarcomatoid Renal Cell Carcinoma	SHANK1 ERBB2 CASP2 SYNE2	5.28e-03	128	160	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	SHANK1 ERBB2 CASP2 SYNE2	5.28e-03	128	160	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	SHANK1 ERBB2 CASP2 SYNE2	5.28e-03	128	160	4	C1266044
Disease	Papillary Renal Cell Carcinoma	SHANK1 ERBB2 CASP2 SYNE2	5.28e-03	128	160	4	C1306837
Disease	Renal Cell Carcinoma	SHANK1 ERBB2 CASP2 SYNE2	5.28e-03	128	160	4	C0007134
Disease	susceptibility to cold sores measurement	MUC16 DYSF DCAF10	5.34e-03	65	160	3	EFO_0008402
Disease	bone density	TTF2 MACC1 EPS8L1 PLXND1 RREB1 SLC8A1 ARHGAP25	5.40e-03	388	160	7	EFO_0003923

Protein segments in the cluster

Peptide	Gene	Start	Entry
GMEHLREVRAVTSAN	ERBB2	346	P04626
RSDLMFEKQSERHGL	CHRND	396	Q07001
VARGKAMVRSHRVTT	BTNL10	106	A8MVZ5
EGRNAEKVSQMLRHF	ADCK1	236	Q86TW2
GHRRTESEMSARIAK	ANKLE2	786	Q86XL3
SHGRFKRRMTERDVE	CHD8	1466	Q9HCK8
DSEHMQEAAGIRKSS	CORT	31	O00230
GKTFTRRNTMARHAD	CTCF	561	P49711
HATQRVMEAEQTKTR	SH3BP5	161	O60239
RAREEHTSAVNKMFS	FBXO4	246	Q9UKT5
RATRDLVDDMGRHKS	ATP8B3	196	O60423
LVDDMGRHKSDRAIN	ATP8B3	201	O60423
DAHEMRTALRKAGFT	CAPN8	626	A6NHC0
HRRTMRDQDTGKENE	CLSTN1	886	O94985
MAEARAVSRKAANTA	CEP170B	1211	Q9Y4F5
DVDSQIRAEMHRKTA	CFAP44	981	Q96MT7
MTRTFHDLEGNAVKR	ERMP1	691	Q7Z2K6
GSVHIEVREVAMSKN	ADAMTS6	741	Q9UKP5
DFMTEHERKGRTAVL	ATP7A	1201	Q04656
LNDRSRSHSGKVEMK	CPXCR1	106	Q8N123
EKPMEGESRNRNVHS	ITIH4	606	Q14624
RRSPTHEKNTMGAQE	OPALIN	86	Q96PE5
MNSGKAHERARAVNT	MROH7	571	Q68CQ1
DTAGQERFRKSMVEH	RAB33A	91	Q14088
MSLKSERRGIHVDQS	RABGEF1	1	Q9UJ41
HSSGTKETRLELREM	GDF2	261	Q9UK05
AMDRAHRLGQTKQVT	INO80	1206	Q9ULG1
NGHVFRKQALMSEER	ARHGEF28	1071	Q8N1W1
DRRNSMKLQHAASVT	ARHGEF17	1761	Q96PE2
GQETRFAEGIRHMKS	FBLN7	46	Q53RD9
EDMRHPGSRKFNTTE	MUC16	13026	Q8WXI7
VHRMNSAEGRRKAFA	OR2T2	226	Q6IF00
HEQEMSRTVKVRDGE	JAKMIP2	96	Q96AA8
GSAINSRETMFHKER	PRKCQ	211	Q04759
NERSMGDHNERVHKR	MDN1	5106	Q9NU22
SERTKPRMHEFQSEV	KLHL6	306	Q8WZ60
SSRSTHNEMEKNRRA	MXD1	56	Q05195
TSRVVHIMDFQRGKN	MATR3	396	P43243
RHGQGRSLEAEDKMT	GPANK1	91	O95872
EMNRKHSGSRSDEDR	CWC22	856	Q9HCG8
SRRMVSSGLVHINDK	C2CD6	591	Q53TS8
TSRMHQRFLDGKDGD	CCDC97	286	Q96F63
SKKTRRHTEGMQADA	COL11A1	1551	P12107
EDAGARARHKMTIAA	MYH14	1821	Q7Z406
RSLKRTHDMFVADNG	PLRG1	16	O43660
MAGKAHRLSAEERDQ	PCBD1	1	P61457
QDHVTVEMSVRVNGR	PLXND1	676	Q9Y4D7
ATLADQRRAAHESKM	IPO7	996	O95373
AVAGVMITASHNRKE	PGM2L1	166	Q6PCE3
SSEKHMSRASQREGV	DCAF10	376	Q5QP82
FLTAMRQEVTRAHKG	DNAH8	4356	Q96JB1
EARQHNTEIRMAVSK	FKBP15	511	Q5T1M5
VHAGSAKAAVDAMTR	DECR2	176	Q9NUI1
SQIEDAMRKAGVAHS	MED15	21	Q96RN5
HTDVGSVRMRRAEKS	NEK8	266	Q86SG6
RVAHMETSLGQARER	NES	196	P48681
VLRAVEQAMGHSQDR	LRRC45	216	Q96CN5
EEMAKSSRASAARVG	LRRC45	271	Q96CN5
MRKRTNALVHSESDV	GABRA4	386	P48169
RMERVARHSSVSKEE	TUBGCP6	646	Q96RT7
RNDVSHVVKGAMVAT	RPS6KA6	696	Q9UK32
GVMRVRNVKESAAHD	PTPN11	381	Q06124
HRMNSAEGRRKAFAT	OR2T35	226	Q8NGX2
ETQHRSMKEKGRIAA	GOLGA3	626	Q08378
GRALAMAESTEKHAR	HUWE1	2161	Q7Z6Z7
SQHILLRGDKTSRDM	NLRC5	1071	Q86WI3
RARHQQMSGDVAVEK	MAST1	886	Q9Y2H9
RFGSKAHMERLEEVN	NOS1	376	P29475
IAATVAHRRKSMEAS	PRTG	206	Q2VWP7
QEVVAQARLDGHRSM	NEU2	71	Q9Y3R4
DTVDNEHMGRRSSKC	PPP1R11	46	O60927
FHIRRVMKTGGENTD	FZD10	421	Q9ULW2
ADDHIARRTAQKIMA	DPYSL4	546	O14531
QRLRDKTDGAMQAHE	CROCC	571	Q5TZA2
KDLTEAHSRMSDLRG	FHAD1	1016	B1AJZ9
AHSRMSDLRGELNEK	FHAD1	1021	B1AJZ9
EFDVVFHSQKVGRMR	HYDIN	3571	Q4G0P3
TDKARMARHVLDNSG	DCAKD	166	Q8WVC6
AFSRAHRIGQANKVM	CHD3	1166	Q12873
HRRNTSMEPAAETGK	C4orf17	231	Q53FE4
MTEQIRQDRSKGTVH	COL6A2	141	P12110
SAVMGHRSDVEAIAK	CYBC1	141	Q9BQA9
QARSGGDERKARMHE	CC2D1B	401	Q5T0F9
EDTAGSRTGRKQHMK	DNAAF8	466	Q8IYS4
NSMRRVKEDTAAHIA	CEP162	1206	Q5TB80
QDKHSIRARVARAMS	CRHR1	411	P34998
RKHFRSGRIAQSMSE	MACC1	6	Q6ZN28
ASMEEVFHRRQASLK	MCF2L	541	O15068
DARDHSGATARMLAK	ANKS3	196	Q6ZW76
NANARMKAHVRRGTA	DNAAF4	361	Q8WXU2
EHMGSSSRDRRQKGK	KMT2A	2416	Q03164
MAHEGSRQVRDRGVT	C2orf81	1	A6NN90
KRKEMEASGAHRDSQ	CCDC174	121	Q6PII3
RHVDKGTAEGAVDAM	EMC1	76	Q8N766
RQHATNVGIMFRDKE	FAH	131	P16930
VGRHSPASEEMKRQN	CCDC168	2636	Q8NDH2
MVAERTHKAAATGAR	COL13A1	1	Q5TAT6
AAQKAVRAMAVLTDH	DDAH2	191	O95865
GVHTVEDASRKLAVM	EPS8L1	51	Q8TE68
IRFHMASDREGTKIQ	FARP2	231	O94887
VSAHTRAVKERMDRQ	CAVIN2	121	O95810
TVHQRRNGSKDSLME	EPB41L4A	641	Q9HCS5
DHETMGRNRFLGEAK	DYSF	71	O75923
TFQHKELMAADRGRR	CASP2	11	P42575
DHMFTEARGSRLNKG	COL6A6	896	A6NMZ7
HVTSRFKNEVERMGF	MTMR3	156	Q13615
SNHRRRTADAEIKMQ	PRDM2	1511	Q13029
AARERGSHDNITVMV	PPM1F	396	P49593
RAHTGMARSKDSVVL	NUTM2A	686	Q8IVF1
HRKEAFSIGMQRDLS	PLEKHA8P1	361	O95397
MRVETAADGKTTRHN	GTF2E1	76	P29083
FATMRRKEGTSVLEH	UTP15	491	Q8TED0
HSVAKETARRRAMLD	SNAPIN	111	O95295
KDEHSKTNRMTGREF	THADA	1271	Q6YHU6
SMRVFDERHKKENGT	TBX3	321	O15119
AGMFDQKSSSHERRA	SMARCA2	1201	P51531
ENRTDTASRLKQMVH	SYNE2	6206	Q8WXH0
EAVRAKNMARRAHSA	KIF5C	906	O60282
VFRDNSRELHTMTKA	NKPD1	471	Q17RQ9
FSRETDGAQKRRMLH	ING1	201	Q9UK53
VQHGSRALATKDMRK	SMG1	121	Q96Q15
KMSSEERRAHRDGTV	PLEKHA7	506	Q6IQ23
SVQHGSRALATKDMR	nan	116	Q6P435
AGMFDQKSSSHERRA	SMARCA4	1231	P51532
SVGFMDTRKRHQSDG	SIPA1L1	1496	O43166
GTESMTHADAQDRIK	PDLIM3	56	Q53GG5
RGDAVAKASKETHVM	PSME2	171	Q9UL46
KQASRLREEAHNMGT	WAC	581	Q9BTA9
QRHKEAEAERCGSMT	IQANK1	301	A8MXQ7
HQMVRTDSREQKLDA	MLH1	381	P40692
RIVMGDTHKSQRLAS	PEX12	91	O00623
MAEKRHTRDSEAQRL	STOM	1	P27105
NMRAKGHPERVFSVT	SV2A	381	Q7L0J3
TAGQEDTIQREGHMR	RERG	61	Q96A58
GMTALHKAARARNQV	SHANK2	231	Q9UPX8
DFRARDGMTALHKAA	SHANK1	241	Q9Y566
RMRVKAIFSHAAGDN	BAIAP2	376	Q9UQB8
VEEQIDRMRRHQSGS	PLEKHA6	821	Q9Y2H5
GDHTNRVKRIATAPM	WDTC1	131	Q8N5D0
RIVDKMHDSNTGIRS	PLEK2	131	Q9NYT0
VKNSAESEGMRRAHI	XPNPEP1	321	Q9NQW7
ESEGMRRAHIKDAVA	XPNPEP1	326	Q9NQW7
RCRKSHGEVTQKDDM	VPS13A	2461	Q96RL7
EGTRFTETKHRVSME	AGPAT3	176	Q9NRZ7
KNVMVSTGRDRQTNH	TUBG1	301	P23258
HMAVTRSRKEGLASA	RREB1	1611	Q92766
AKAGEGHRRTMSQDL	ARHGAP25	476	P42331
HLTRDGERKSMSVER	POLK	406	Q9UBT6
GAKMSDHRERLRNSA	TLNRD1	316	Q9H1K6
NMQGRVDHTVASDIR	USF3	1716	Q68DE3
LEKTREERFTMGHSA	SPTA1	111	P02549
RDLNRMHEATSAETK	USP28	121	Q96RU2
EREMGSNPHDTNKRE	ZNF697	36	Q5TEC3
KNVMVSTGRDRQTNH	TUBG2	301	Q9NRH3
EVFKVRHRASGQVMA	TESK2	71	Q96S53
HGEAGVRRIKMATAD	TKFC	221	Q3LXA3
AVHVAGMAQEDSRRG	ZNF652	16	Q9Y2D9
EMQGHLKRASNESTR	TBL2	411	Q9Y4P3
VGHRDSMDLQRFKET	TRPM7	1441	Q96QT4
ENRKRHGSSRSVVDM	UBR5	2476	O95071
KQRMDLVEAFNHSRG	TTF2	1046	Q9UNY4
KIGDSSVETHRNREM	ZMAT1	416	Q5H9K5
MDISRGNHRDNKAVI	UNC79	2371	Q9P2D8
EMIQRKGSTFRPHDS	KIAA1522	131	Q9P206
RHAADQARKAVSMHE	SLC8A1	381	P32418
IADETGRVMHDITSK	MYO3B	561	Q8WXR4
RGSAEAVVMARSHIQ	N4BP1	121	O75113
EQKEERQHSLRMGSS	MYOM3	31	Q5VTT5
ETRKMFERSVHESGQ	PPP1R9A	141	Q9ULJ8
KANARERTRMHGLND	NEUROD4	91	Q9HD90
AVLSTRKHEQMFREA	GRIN1	31	Q05586